URECE
Live / Registered — Registered (as of 24 Nov 2020)
What this means for you
Registered since 24 Nov 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 affidavit of use was filed 24 Apr 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 79287989
- Registration number
- 6202941
- Mark type
- Word mark
- Filed
- 11 May 2020
- Published for opposition
- 08 Sept 2020
- Registered
- 24 Nov 2020
- Next maintenance filing
- §71 affidavit of use, filed 24 Apr 2026 — awaiting the USPTO's acceptance
- Attorney of record
- Brian E. Ainsworth
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparation for the treatment of hyperuricemia; pharmaceutical preparation for the treatment of gout; chemical preparations for pharmaceutical or medical purposes, namely, for uric acid reabsorption inhibition, and uric acid excretion promotion
Owner
- FUJI YAKUHIN CO., LTD., Saitama 330-0854, JP
- FUJI YAKUHIN CO., LTD., JP
- FUJI YAKUHIN CO., LTD., JP
Prosecution history
- 20 Aug 2026 — POST REGISTRATION ACTION MAILED - SEC.71
- 10 Aug 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Apr 2026 — TEAS SECTION 71 RECEIVED
- 19 Dec 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 02 Jun 2022 — CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
- 22 May 2022 — CORRECTION TRANSACTION RECEIVED FROM IB
- 30 Jan 2021 — NOTIFICATION PROCESSED BY IB
- 14 Jan 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 14 Jan 2021 — FINAL DISPOSITION PROCESSED
- 24 Dec 2020 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 24 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 08 Sept 2020 — PUBLISHED FOR OPPOSITION
- 19 Aug 2020 — NOTICE OF PUBLICATION
- 06 Aug 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Aug 2020 — ASSIGNED TO EXAMINER